Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893425821> ?p ?o ?g. }
- W2893425821 endingPage "1801220" @default.
- W2893425821 startingPage "1801220" @default.
- W2893425821 abstract "The anti-tumour and anti-metastatic properties of heparins have not been tested in patients with early stage cancer. Whether adjuvant low molecular weight heparin (LMWH) tinzaparin impacts the survival of patients with resected non-small cell lung cancer (NSCLC) was investigated.Patients with completely resected stage I, II or IIIA NSCLC were randomly allocated to receive subcutaneous tinzaparin 100 IU·kg-1 once a day for 12 weeks or no treatment in addition to standard of care. The trial was open-label with blinded central adjudication of study outcomes. The primary outcome was overall survival.In 549 patients randomised to tinzaparin (n=269) or control (n=280), mean±sd age was 61.6±8.9 years, 190 (34.6%) patients had stage II-III disease, and 220 (40.1%) patients received adjuvant chemotherapy. Median follow-up was 5.7 years. There was no significant difference in overall survival between groups (hazard ratio (HR) 1.24, 95% CI 0.92-1.68; p=0.17). There was no difference in the cumulative incidence of recurrence between groups (subdistribution HR 0.94, 95% CI 0.68-1.30; p=0.70).Adjuvant tinzaparin had no detectable impact on overall and recurrence-free survival of patients with completely resected stage I-IIIA NSCLC. These results do not support further clinical evaluation of LMWHs as anti-tumour agents." @default.
- W2893425821 created "2018-10-05" @default.
- W2893425821 creator A5000029967 @default.
- W2893425821 creator A5002016335 @default.
- W2893425821 creator A5006010044 @default.
- W2893425821 creator A5006321649 @default.
- W2893425821 creator A5009502739 @default.
- W2893425821 creator A5010033165 @default.
- W2893425821 creator A5011709141 @default.
- W2893425821 creator A5016370905 @default.
- W2893425821 creator A5021624793 @default.
- W2893425821 creator A5022875313 @default.
- W2893425821 creator A5023080520 @default.
- W2893425821 creator A5023794502 @default.
- W2893425821 creator A5025003700 @default.
- W2893425821 creator A5034873604 @default.
- W2893425821 creator A5040358110 @default.
- W2893425821 creator A5043227482 @default.
- W2893425821 creator A5044106510 @default.
- W2893425821 creator A5045700114 @default.
- W2893425821 creator A5047402540 @default.
- W2893425821 creator A5052251865 @default.
- W2893425821 creator A5054042634 @default.
- W2893425821 creator A5054966303 @default.
- W2893425821 creator A5058307886 @default.
- W2893425821 creator A5059886680 @default.
- W2893425821 creator A5063966015 @default.
- W2893425821 creator A5066711680 @default.
- W2893425821 creator A5069581129 @default.
- W2893425821 creator A5069871091 @default.
- W2893425821 creator A5070371776 @default.
- W2893425821 creator A5071118692 @default.
- W2893425821 creator A5083009158 @default.
- W2893425821 creator A5083020460 @default.
- W2893425821 creator A5087883382 @default.
- W2893425821 creator A5089460437 @default.
- W2893425821 creator A5090503947 @default.
- W2893425821 date "2018-09-27" @default.
- W2893425821 modified "2023-10-10" @default.
- W2893425821 title "Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial" @default.
- W2893425821 cites W1046005609 @default.
- W2893425821 cites W1892833185 @default.
- W2893425821 cites W1991879020 @default.
- W2893425821 cites W1993312546 @default.
- W2893425821 cites W1996544895 @default.
- W2893425821 cites W1996552399 @default.
- W2893425821 cites W2037490988 @default.
- W2893425821 cites W2088720324 @default.
- W2893425821 cites W2090436854 @default.
- W2893425821 cites W2104504726 @default.
- W2893425821 cites W2117994949 @default.
- W2893425821 cites W2128894055 @default.
- W2893425821 cites W2138368121 @default.
- W2893425821 cites W2141100626 @default.
- W2893425821 cites W2142386661 @default.
- W2893425821 cites W2144169464 @default.
- W2893425821 cites W2150238019 @default.
- W2893425821 cites W2154099252 @default.
- W2893425821 cites W2160638301 @default.
- W2893425821 cites W2196970594 @default.
- W2893425821 cites W2314635417 @default.
- W2893425821 cites W2571766406 @default.
- W2893425821 cites W4236098165 @default.
- W2893425821 cites W4247355438 @default.
- W2893425821 cites W4299883346 @default.
- W2893425821 doi "https://doi.org/10.1183/13993003.01220-2018" @default.
- W2893425821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30262574" @default.
- W2893425821 hasPublicationYear "2018" @default.
- W2893425821 type Work @default.
- W2893425821 sameAs 2893425821 @default.
- W2893425821 citedByCount "40" @default.
- W2893425821 countsByYear W28934258212019 @default.
- W2893425821 countsByYear W28934258212020 @default.
- W2893425821 countsByYear W28934258212021 @default.
- W2893425821 countsByYear W28934258212022 @default.
- W2893425821 countsByYear W28934258212023 @default.
- W2893425821 crossrefType "journal-article" @default.
- W2893425821 hasAuthorship W2893425821A5000029967 @default.
- W2893425821 hasAuthorship W2893425821A5002016335 @default.
- W2893425821 hasAuthorship W2893425821A5006010044 @default.
- W2893425821 hasAuthorship W2893425821A5006321649 @default.
- W2893425821 hasAuthorship W2893425821A5009502739 @default.
- W2893425821 hasAuthorship W2893425821A5010033165 @default.
- W2893425821 hasAuthorship W2893425821A5011709141 @default.
- W2893425821 hasAuthorship W2893425821A5016370905 @default.
- W2893425821 hasAuthorship W2893425821A5021624793 @default.
- W2893425821 hasAuthorship W2893425821A5022875313 @default.
- W2893425821 hasAuthorship W2893425821A5023080520 @default.
- W2893425821 hasAuthorship W2893425821A5023794502 @default.
- W2893425821 hasAuthorship W2893425821A5025003700 @default.
- W2893425821 hasAuthorship W2893425821A5034873604 @default.
- W2893425821 hasAuthorship W2893425821A5040358110 @default.
- W2893425821 hasAuthorship W2893425821A5043227482 @default.
- W2893425821 hasAuthorship W2893425821A5044106510 @default.
- W2893425821 hasAuthorship W2893425821A5045700114 @default.
- W2893425821 hasAuthorship W2893425821A5047402540 @default.
- W2893425821 hasAuthorship W2893425821A5052251865 @default.
- W2893425821 hasAuthorship W2893425821A5054042634 @default.